Last edition
News about Global Pharma
Cellipont Bioservices and Adva Biotechnology Unveil ADVA X3 Platform
Cellipont Bioservices has joined hands with Adva Biotechnology, marking the launch of the groundbreaking ADVA X3 platform in North America.
Global Pharma | 09/05/2024 | By Aishwarya | 707
Avidity Biosciences' Delpacibart Etedesiran Receives FDA Breakthrough Therapy Designation
Despite its severity, there are currently no approved therapies for DM1, making the FDA's recognition of delpacibart etedesiran's potential all the more crucial.
Global Pharma | 09/05/2024 | By Abha | 682
4C Medical's AltaValve System Granted Breakthrough Device Designation by FDA
The FDA has granted the AltaValve System Breakthrough Device designations for two therapeutic indications.
Global Pharma | 09/05/2024 | By Abha | 1253
ExcellGene Signs Strategic Partnership with Cytovance Biologics
ExcellGene has forged its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization (CDMO) based in the USA.
Global Pharma | 09/05/2024 | By Aishwarya | 634
Lindus Health Appoints Dr. Tim Garnett to their Advisory Board
Dr. Garnett is a board member of leading biotechs like Maplight Therapeutics and Ophirex, Inc., as well as an advisor to Ukko and Biolojic Design.
Global Pharma | 08/05/2024 | By Manvi | 1215
Grand River Aseptic Manufacturing Opens New Syringe and Cartridge Filling Center
Grand River Aseptic Manufacturing has launched its third world-class facility in five years.
Global Pharma | 08/05/2024 | By Aishwarya | 835
This achievement marks the first spine device treated with a coating designed to reduce bacterial contamination in the operating room.
Global Pharma | 08/05/2024 | By Abha | 912
Gland Pharma Receives Nod from US FDA for Rare Muscle Disorder
Gland Pharma Ltd. has received approval from the US health regulator for its generic Edaravone injection to treat amyotrophic lateral sclerosis.
Global Pharma | 08/05/2024 | By Aishwarya | 988
ASPA Introduces Consumer Awareness Campaigns to Combat Counterfeiting in Pharma
The Authentication Solution Providers' Association (ASPA), a proactive advocate in the fight against counterfeiting, has announced to be spearheading a robust public awareness campaign, particularly within the pharmaceutical industry.
Global Pharma | 08/05/2024 | By Aishwarya | 991
Biotheryx Announces US FDA Clearance of Investigational New Drug Application for BTX-9341
The Company plans to initiate the Phase 1 clinical trial in the second half of 2024 and intends to enroll patients with HR+/HER2- breast cancer resistant to CDK4/6 inhibitor therapies.
Global Pharma | 07/05/2024 | By Manvi | 341
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy